S80884 |
Fenoldopam Mesylate |
源葉(MedMol) | 99% |
Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.488 ml | 12.442 ml | 24.884 ml |
5 mM | 0.498 ml | 2.488 ml | 4.977 ml |
10 mM | 0.249 ml | 1.244 ml | 2.488 ml |
50 mM | 0.05 ml | 0.249 ml | 0.498 ml |
- 提示:詳情請下載說明書。
- 產(chǎn)品描述:
Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis
- 靶點: IC50: 0.8974 μM (LSD1);DopamineReceptor
- 體內(nèi)研究:
Fenoldopam mesylate (subcutaneous injection; 100 mg/kg; once daily; 2 d) can induce arteritis in rats detected by magnetic resonance imaging (MRI)
- 參考文獻:
1. A Grenader, et al. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells. J Pharmacol Exp Ther. 1991 Jul 1;258(1):193-8. 2. Yan Zheng, et al. Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. Bioorg Chem. 2021 Mar;108:104561. 3. Yuta Fujii, et al. Detection of fenoldopam-induced arteritis in rats using ex vivo / in vivo MRI. Toxicology Reports, Volume 9, 2022, Pages 1595-1602.
- 溶解性: Soluble in DMSO、H2O
- 保存條件: RT
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 2.488 ml 12.442 ml 24.884 ml 5 mM 0.498 ml 2.488 ml 4.977 ml 10 mM 0.249 ml 1.244 ml 2.488 ml 50 mM 0.05 ml 0.249 ml 0.498 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:
本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)